tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

DRTS Stock Latest News

Alpha Tau Expands Alpha DaRT Into Recurrent Prostate Cancer: What Investors Should Watch
Company AnnouncementsAlpha Tau Expands Alpha DaRT Into Recurrent Prostate Cancer: What Investors Should Watch
7d ago
DRTS
Alpha Tau Medical to Present Corporate Update at J.P. Morgan 2026 Healthcare Conference
PremiumCompany Announcements
Alpha Tau Medical to Present Corporate Update at J.P. Morgan 2026 Healthcare Conference
7d ago
6K
DRTS
Alpha Tau Medical’s Innovative Prostate Cancer Therapy: Study Completion Update
PremiumCompany Announcements
Alpha Tau Medical’s Innovative Prostate Cancer Therapy: Study Completion Update
11d ago
DRTS
Alpha Tau Medical’s Innovative Cancer Treatment Study Update: A Potential Game-Changer
PremiumCompany Announcements
Alpha Tau Medical’s Innovative Cancer Treatment Study Update: A Potential Game-Changer
11d ago
DRTS
Promising Clinical Developments and Innovative Technology Drive Buy Rating for Alpha Tau Medical Ltd
PremiumRatings
Promising Clinical Developments and Innovative Technology Drive Buy Rating for Alpha Tau Medical Ltd
15d ago
DRTS
Alpha Tau price target lowered to $7 from $8 at Citi
PremiumThe FlyAlpha Tau price target lowered to $7 from $8 at Citi
15d ago
DRTS
Optimistic Growth Prospects and Strategic Developments Drive Buy Rating for Alpha Tau Medical Ltd
Premium
Ratings
Optimistic Growth Prospects and Strategic Developments Drive Buy Rating for Alpha Tau Medical Ltd
15d ago
DRTS
Alpha Tau Treats First U.S. Patient with Alpha DaRT for Glioblastoma
Premium
Company Announcements
Alpha Tau Treats First U.S. Patient with Alpha DaRT for Glioblastoma
16d ago
6K
DRTS
Alpha Tau announces first patient treated in study using Alpha DaRT tech
PremiumThe Fly
Alpha Tau announces first patient treated in study using Alpha DaRT tech
16d ago
DRTS
Alpha Tau Medical to Present Pancreatic Cancer Research at 2026 ASCO Symposium
PremiumCompany Announcements
Alpha Tau Medical to Present Pancreatic Cancer Research at 2026 ASCO Symposium
21d ago
6K
DRTS
Alpha Tau announces two Alpha DaRT abstracts at ASCO Symposium
PremiumThe Fly
Alpha Tau announces two Alpha DaRT abstracts at ASCO Symposium
21d ago
DRTS
Alpha Tau Medical Receives FDA Approval for Prostate Cancer Trial
PremiumCompany Announcements
Alpha Tau Medical Receives FDA Approval for Prostate Cancer Trial
23d ago
6K
DRTS
Alpha Tau receives FDA approved IDE application to initiate study of Alpha DaRT
PremiumThe FlyAlpha Tau receives FDA approved IDE application to initiate study of Alpha DaRT
23d ago
DRTS
Promising Developments and Strategic Trials Support Buy Rating for Alpha Tau Medical Ltd.
Premium
Ratings
Promising Developments and Strategic Trials Support Buy Rating for Alpha Tau Medical Ltd.
1M ago
DRTS
Alpha Tau Medical Reports Q3 2025 Progress and Financials
Premium
Company Announcements
Alpha Tau Medical Reports Q3 2025 Progress and Financials
1M ago
DRTS
Alpha Tau Medical Reports Q3 2025 Results and Advances in Cancer Therapy
PremiumCompany Announcements
Alpha Tau Medical Reports Q3 2025 Results and Advances in Cancer Therapy
1M ago
6K
DRTS
Alpha Tau reports Q3 EPS (32c), consensus (12c)
PremiumThe Fly
Alpha Tau reports Q3 EPS (32c), consensus (12c)
1M ago
DRTS
Ten new option listings on November 5th
PremiumThe Fly
Ten new option listings on November 5th
2M ago
AIS
DRTS
Alpha Tau Medical Ltd Receives Buy Rating Amid Strategic Advancements and Promising Developments in Cancer Treatment
PremiumRatings
Alpha Tau Medical Ltd Receives Buy Rating Amid Strategic Advancements and Promising Developments in Cancer Treatment
2M ago
DRTS
Alpha Tau Secures Radioactive Material License for New Hampshire Facility
PremiumCompany AnnouncementsAlpha Tau Secures Radioactive Material License for New Hampshire Facility
2M ago
6K
DRTS
Alpha Tau secures radioactive material license from New Hampshire
Premium
The Fly
Alpha Tau secures radioactive material license from New Hampshire
2M ago
DRTS
Alpha Tau Medical’s Innovative Approach in Pancreatic Cancer Treatment: A Study Update
Premium
Company Announcements
Alpha Tau Medical’s Innovative Approach in Pancreatic Cancer Treatment: A Study Update
4M ago
DRTS

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >